Globus Medical (GMED) — Quality & forensics

As of 2026-08-06 — refreshed nightly. Closelook readings from an investment research diary, not ratings or advice.

The Closelook module scores

66 /100 composite · 7 modules · general weight set

Valuation 74
Quality 58
Growth 79
Balance sheet 80
Cash quality 49
Capital allocation 70
Momentum 34

Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.

Financial forensics — the academic screens

10.58 Altman Z-Score

Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.

8/8 Piotroski F-Score

Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.

-2.50 Beneish M-Score

Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.

Continue: the GMED chart & overview

FAQ · from the current data · as of 2026-08-06

Quick answers

What is Globus Medical's Closelook quality reading?

The composite reads 66/100 across 7 modules, as of 2026-08-06: valuation 74, quality 58, growth 79, balance sheet 80, cash quality 49, capital allocation 70, momentum 34. Closelook scores are research diary readings, not ratings or investment advice.

What is Globus Medical's Altman Z-Score?

10.58, which sits in the safe zone (above 2.99) as of 2026-08-06. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.

What is Globus Medical's Piotroski F-Score?

8 of 8, as of 2026-08-06. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.

What does Globus Medical's Beneish M-Score indicate?

-2.50 — below the −1.78 manipulation-risk threshold, as of 2026-08-06. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.